Vivere Oncotherapies, a UC Berkeley spin-out developing cancer therapies that activate the immune system to detect and destroy cancer cells in immunologically cold tumors, today announced over $10M in ...

The field of cancer immunotherapy has achieved remarkable progress, introducing strategies such as immune checkpoint inhibitors and adoptive cell therapies ...

On Tuesday the American Cancer Society (ACS) released its annual report on cancer statistics in the U.S., and it offered a ...

Glioblastoma (GBM) is one of the most common and aggressive primary brain tumors in adults, carrying an extremely poor ...

Researchers have identified adaptive traits in cancer cells that help tumors resist immunotherapy drugs after extended targeted treatment, revealing new hurdles to effective cancer treatment. A ...

A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and ...

A new dry simulator revolutionizes training for complex endoscopic cancer resection.A research team at Tohoku University, in ...

The molecular understanding of brain tumors has undergone a profound transformation in recent years. Advances in genomics, ...

A new report from the American Cancer Association predicts lung cancer will cause more deaths than any other in 2026.

A research team led by Professor Chen Peng from the College of Chemistry and Molecular Engineering at Peking University has ...

Therapies that target the utilization of fat by tumors and activate a type of cell death dependent on fat molecules may be a ...

TROPION-Lung17 will enroll approximately 400 patients across global sites. Participants are randomized 1:1 to receive either Dato-DXd (6.0 mg/kg intravenously every 3 weeks) or docetaxel (75 mg/m² ...